-
2
-
-
80052948694
-
A hospital-based study of clinical and genetic features of Crohn's disease
-
Wei SC, Ni YH, Yang HI etal. A hospital-based study of clinical and genetic features of Crohn's disease. J. Formos. Med. Assoc. 2011; 110: 600-606.
-
(2011)
J. Formos. Med. Assoc.
, vol.110
, pp. 600-606
-
-
Wei, S.C.1
Ni, Y.H.2
Yang, H.I.3
-
3
-
-
84860240669
-
Long-term follow-up of ulcerative colitis in Taiwan
-
Wei SC, Shieh MJ, Chang MC etal. Long-term follow-up of ulcerative colitis in Taiwan. J. Chin. Med. Assoc. 2012; 75: 151-155.
-
(2012)
J. Chin. Med. Assoc.
, vol.75
, pp. 151-155
-
-
Wei, S.C.1
Shieh, M.J.2
Chang, M.C.3
-
4
-
-
84878697125
-
Differential diagnosis of inflammatory bowel disease: what is the role of colonoscopy
-
Jung SA. Differential diagnosis of inflammatory bowel disease: what is the role of colonoscopy. Clin Endosc 2012; 45: 254-262.
-
(2012)
Clin Endosc
, vol.45
, pp. 254-262
-
-
Jung, S.A.1
-
5
-
-
0036725827
-
Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease
-
Abreu MT, Taylor KD, Lin YC etal. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002; 123: 679-688.
-
(2002)
Gastroenterology
, vol.123
, pp. 679-688
-
-
Abreu, M.T.1
Taylor, K.D.2
Lin, Y.C.3
-
6
-
-
13744264167
-
Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease-an IG-IBD study
-
Annese V, Lombardi G, Perri F etal. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease-an IG-IBD study. Am. J. Gastroenterol. 2005; 100: 84-92.
-
(2005)
Am. J. Gastroenterol.
, vol.100
, pp. 84-92
-
-
Annese, V.1
Lombardi, G.2
Perri, F.3
-
7
-
-
34047139587
-
Inflammatory bowel disease genetics: Nod2
-
Cho JH, Abraham C. Inflammatory bowel disease genetics: Nod2. Annu. Rev. Med. 2007; 58: 401-416.
-
(2007)
Annu. Rev. Med.
, vol.58
, pp. 401-416
-
-
Cho, J.H.1
Abraham, C.2
-
8
-
-
33847016160
-
NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives
-
Devlin SM, Yang H, Ippoliti A etal. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives. Gastroenterology 2007; 132: 576-586.
-
(2007)
Gastroenterology
, vol.132
, pp. 576-586
-
-
Devlin, S.M.1
Yang, H.2
Ippoliti, A.3
-
9
-
-
0012722659
-
Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection
-
Girardin SE, Boneca IG, Viala J etal. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 2003; 278: 8869-8872.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 8869-8872
-
-
Girardin, S.E.1
Boneca, I.G.2
Viala, J.3
-
10
-
-
0037379286
-
CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease
-
Helio T, Halme L, Lappalainen M etal. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 2003; 52: 558-562.
-
(2003)
Gut
, vol.52
, pp. 558-562
-
-
Helio, T.1
Halme, L.2
Lappalainen, M.3
-
11
-
-
13244277880
-
Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing
-
Maeda S, Hsu LC, Liu H etal. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 2005; 307: 734-738.
-
(2005)
Science
, vol.307
, pp. 734-738
-
-
Maeda, S.1
Hsu, L.C.2
Liu, H.3
-
12
-
-
80855128813
-
Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior
-
Lichtenstein GR, Targan SR, Dubinsky MC etal. Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior. Inflamm. Bowel Dis. 2011; 17: 2488-2496.
-
(2011)
Inflamm. Bowel Dis.
, vol.17
, pp. 2488-2496
-
-
Lichtenstein, G.R.1
Targan, S.R.2
Dubinsky, M.C.3
-
13
-
-
48349136889
-
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
-
Barrett JC, Hansoul S, Nicolae DL etal. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 2008; 40: 955-962.
-
(2008)
Nat. Genet.
, vol.40
, pp. 955-962
-
-
Barrett, J.C.1
Hansoul, S.2
Nicolae, D.L.3
-
14
-
-
27944464550
-
Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease
-
Yamazaki K, McGovern D, Ragoussis J etal. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum. Mol. Genet. 2005; 14: 3499-3506.
-
(2005)
Hum. Mol. Genet.
, vol.14
, pp. 3499-3506
-
-
Yamazaki, K.1
McGovern, D.2
Ragoussis, J.3
-
15
-
-
44949240320
-
Association of TNFSF15 with Crohn's disease in Koreans
-
Yang SK, Lim J, Chang HS etal. Association of TNFSF15 with Crohn's disease in Koreans. Am. J. Gastroenterol. 2008; 103: 1437-1442.
-
(2008)
Am. J. Gastroenterol.
, vol.103
, pp. 1437-1442
-
-
Yang, S.K.1
Lim, J.2
Chang, H.S.3
-
16
-
-
10744228695
-
Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease
-
Mow WS, Vasiliauskas EA, Lin YC etal. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 2004; 126: 414-424.
-
(2004)
Gastroenterology
, vol.126
, pp. 414-424
-
-
Mow, W.S.1
Vasiliauskas, E.A.2
Lin, Y.C.3
-
17
-
-
20444441016
-
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease
-
Targan SR, Landers CJ, Yang H etal. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 2005; 128: 2020-2028.
-
(2005)
Gastroenterology
, vol.128
, pp. 2020-2028
-
-
Targan, S.R.1
Landers, C.J.2
Yang, H.3
-
18
-
-
0033805362
-
Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics
-
Vasiliauskas EA, Kam LY, Karp LC etal. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics. Gut 2000; 47: 487-496.
-
(2000)
Gut
, vol.47
, pp. 487-496
-
-
Vasiliauskas, E.A.1
Kam, L.Y.2
Karp, L.C.3
-
19
-
-
43449118677
-
Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years
-
Hoie O, Aamodt G, Vermeire S etal. Serological markers are associated with disease course in ulcerative colitis. A study in an unselected population-based cohort followed for 10 years. J Crohns Colitis 2008; 2: 114-122.
-
(2008)
J Crohns Colitis
, vol.2
, pp. 114-122
-
-
Hoie, O.1
Aamodt, G.2
Vermeire, S.3
-
20
-
-
8744240536
-
A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients
-
Lawrance IC, Murray K, Hall A etal. A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients. Am. J. Gastroenterol. 2004; 99: 2186-2194.
-
(2004)
Am. J. Gastroenterol.
, vol.99
, pp. 2186-2194
-
-
Lawrance, I.C.1
Murray, K.2
Hall, A.3
-
21
-
-
77955055367
-
The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China
-
Zhou F, Xia B, Wang F etal. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China. Clin. Chim. Acta 2010; 411: 1461-1465.
-
(2010)
Clin. Chim. Acta
, vol.411
, pp. 1461-1465
-
-
Zhou, F.1
Xia, B.2
Wang, F.3
-
22
-
-
0036677319
-
Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease
-
Kim BG, Kim YS, Kim JS etal. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. Dis. Colon Rectum 2002; 45: 1062-1069.
-
(2002)
Dis. Colon Rectum
, vol.45
, pp. 1062-1069
-
-
Kim, B.G.1
Kim, Y.S.2
Kim, J.S.3
-
23
-
-
0037300418
-
Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: diagnostic accuracy and clinical value
-
Hisabe T, Matsui T, Sakurai T etal. Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: diagnostic accuracy and clinical value. J. Gastroenterol. 2003; 38: 121-126.
-
(2003)
J. Gastroenterol.
, vol.38
, pp. 121-126
-
-
Hisabe, T.1
Matsui, T.2
Sakurai, T.3
-
24
-
-
33646778482
-
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
-
Satsangi J, Silverberg MS, Vermeire S etal. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-753.
-
(2006)
Gut
, vol.55
, pp. 749-753
-
-
Satsangi, J.1
Silverberg, M.S.2
Vermeire, S.3
-
25
-
-
13444269543
-
Haploview: analysis and visualization of LD and haplotype maps
-
Barrett JC, Fry B, Maller J etal. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
-
(2005)
Bioinformatics
, vol.21
, pp. 263-265
-
-
Barrett, J.C.1
Fry, B.2
Maller, J.3
-
26
-
-
61849115157
-
IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein
-
Michelsen KS, Thomas LS, Taylor KD etal. IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein. PLoS One 2009; 4: e4719.
-
(2009)
PLoS One
, vol.4
-
-
Michelsen, K.S.1
Thomas, L.S.2
Taylor, K.D.3
-
27
-
-
84883182349
-
TL1A/TNFSF15 directly induces proinflammatory cytokines, including TNFalpha, from CD3+CD161+ T cells to exacerbate gut inflammation
-
Jin S, Chin J, Seeber S etal. TL1A/TNFSF15 directly induces proinflammatory cytokines, including TNFalpha, from CD3+CD161+ T cells to exacerbate gut inflammation. Mucosal Immunol. 2013; 6: 886-899.
-
(2013)
Mucosal Immunol.
, vol.6
, pp. 886-899
-
-
Jin, S.1
Chin, J.2
Seeber, S.3
-
28
-
-
84862927426
-
Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis
-
Barrett R, Zhang X, Koon HW etal. Constitutive TL1A expression under colitogenic conditions modulates the severity and location of gut mucosal inflammation and induces fibrostenosis. Am. J. Pathol. 2012; 180: 636-649.
-
(2012)
Am. J. Pathol.
, vol.180
, pp. 636-649
-
-
Barrett, R.1
Zhang, X.2
Koon, H.W.3
|